Conjugation to 4-aminoquinoline improves the anti-trypanosomal activity of Deferiprone-type iron chelators |
| |
Authors: | Sebastian S Gehrke Erika G Pinto Dietmar Steverding Karin Pleban Andre G Tempone Robert C Hider Gerd K Wagner |
| |
Institution: | 1. Institute of Pharmaceutical Science, School of Biomedical Sciences, King’s College London, SE19NH, UK;2. School of Pharmacy, University of East Anglia, Norwich NR4 7TJ, UK;3. BioMedical Research Centre, Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK;4. Department of Parasitology, Instituto Adolfo Lutz, São Paulo, Brazil;5. Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo, Brazil;6. Department of Chemistry, School of Biomedical Sciences, King’s College London, SE19NH, UK |
| |
Abstract: | Iron is an essential growth component in all living organisms and plays a central role in numerous biochemical processes due to its redox potential and high affinity for oxygen. The use of iron chelators has been suggested as a novel therapeutic approach towards parasitic infections, such as malaria, sleeping sickness and leishmaniasis. Known iron chelating agents such as Deferoxamine and the 3-hydroxypyridin-4-one (HPO) Deferiprone possess anti-parasitic activity but suffer from mammalian toxicity, relatively modest potency, and/or poor oral availability. In this study, we have developed novel derivatives of Deferiprone with increased anti-parasitic activity and reduced cytotoxicity against human cell lines. Of particular interest are several new derivatives in which the HPO scaffold has been conjugated, via a linker, to the 4-aminoquinoline ring system present in the known anti-malaria drug Chloroquine. We report the inhibitory activity of these novel analogues against four parasitic protozoa, Trypanosoma brucei, Trypanosoma cruzi, Leishmania infantum and Plasmodium falciparum, and, for direct comparison, against human cells lines. We also present data, which support the hypothesis that iron starvation is the major cause of growth inhibition of these new Deferiprone–Chloroquine conjugates in T. brucei. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|